HIGH-GRADE B-CELL LYMPHOMA
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell attack tested for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists track patients for 15 years after revolutionary cancer cell therapy
Disease control Not yet recruitingThis study aims to monitor the long-term safety and persistence of a CAR-T cell therapy called GF-CART01 for up to 15 years. It will follow 18 patients who previously received this treatment for aggressive B-cell lymphomas that have returned or not responded to other therapies. T…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists track brain fog in cancer patients after revolutionary CAR-T treatment
Knowledge-focused Not yet recruitingThis study aims to understand how CAR-T cell therapy affects memory, thinking skills, and quality of life in adults with certain aggressive lymphomas. Researchers will follow 100 patients in Italy for two years, starting assessments before treatment and checking in at 6, 12, and …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC